Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw strong trading volume on Monday . 87,366 shares were traded during mid-day trading, an increase of 139% from the previous session's volume of 36,516 shares.The stock last traded at $70.01 and had previously closed at $69.85.
Novozymes A/S Stock Down 0.5%
The company has a quick ratio of 1.04, a current ratio of 1.66 and a debt-to-equity ratio of 0.11. The company's fifty day simple moving average is $71.50 and its 200 day simple moving average is $63.57. The firm has a market capitalization of $32.65 billion, a PE ratio of 44.12, a price-to-earnings-growth ratio of 1.33 and a beta of 0.91.
Novozymes A/S Company Profile
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Recommended Stories
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access